Recent Headlines
Conquer High Cholesterol Thoroughly
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target High Cholesterol. This natural treatment formula is a comprehensive approach to lower cholesterol, aiming for optimum cardiovascular health. Red Yeast Rice in the formula can inhibit cholesterol production in the liver and may lower cholesterol levels. - January 29, 2008 - Mitamins Inc.
AnaSpec Introduces 9 New Antibody Products
Continuing to rapidly expand its antibody offerings, AnaSpec added nine (9) new antibody products to its growing collection. Anti-AKT pan (IN) - Cat# 54320, 50 µg Host: rabbit polyclonal; Species Reactivity: human; mouse; rat; bovine; zebrafish; Applications: WB Anti-AKT pan (NT) - Cat#... - January 27, 2008 - AnaSpec, EGT Group
Dr Balch High Blood Pressure Formula
Mitamins launches Dr Balch’s High Blood Pressure condition specific supplement formula: Vitamin C 100mg, Calcium 100mg, Magnesium 50mg, CoQ-10 60mg, Flax Seed Powder 50mg, Bioflavonoid Concentrate 100mg, Garlic Extract 100mg, Hawthorn Extract 250mg, Reishi Extract 50mg, Taurine... - January 27, 2008 - Mitamins Inc.
Xcelience Expands Its Early Drug Development Capabilities
The Tampa-based CRO is first to acquire next generation Xcelodose. - January 26, 2008 - Xcelience, LLC
Minimizing and Treating Sebaceous Cysts
Mitamins has launched a new supplement formula from Dr. Balch especially designed to target Sebaceous Cysts. This natural treatment formula is targeted at building the body's natural clearance and preventative processes, which work against sebaceous cysts. The formula includes all the essential natural ingredients to target this condition. - January 24, 2008 - Mitamins Inc.
AnaSpec Announces a Broad Selection of T-Cell Epitopes
AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, EGT Group
Control Lupus Symptoms, Lead a Full Life
At Mitamins, a new supplement formula targeted at Lupus from Dr. Balch has been launched. This natural lupus treatment formula is designed to control the symptoms of lupus as well as promote overall health. Botanicals, such as ginger, having strong anti-inflammatory properties are included. The... - January 23, 2008 - Mitamins Inc.
Improve Quality of Life with Supplement Targeting Hypothyroidism
Mitamins launches a formula by Dr. Balch that is specified to target Hypothyroidism. It contains Vitamins A, C, D, E, K, B-6, and B-12, as well as the nutrients Calcium, Iodine, Magnesium, Thiamin, Riboflavin, Niacin, Folate, Biotin, Copper, Selenium, Maganese, Chromium, Potassium, Pantothenic... - January 21, 2008 - Mitamins Inc.
Relief from Tinnitus
Dr. Balch has launched a Mitamins supplement designed to target Tinnitus. This supplement contains Vitamins B-12 and B-6, as well as the nutrients Thiamin, Riboflavin, Niacin, Folate, Biotin, Magnesium, Zinc, Copper, and Pantothenic Acid. It also includes Choline Bitartrate, Inositol, PABA, and Gingko Extract. - January 21, 2008 - Mitamins Inc.
Defeat Narcolepsy the Natural Way
Mitamins launches a new formula from Dr. Balch that is specified to target Narcolepsy. This supplement contains a complete spectrum of B vitamins, which are especially nourishing to the brain: Thiamin, Riboflavin, Niacin, Vitamin B12, Folate, Pantothenic Acid and Vitamin B6. The formula also includes an Amino Acid Mix, as well as L-Tyrosine, L-Glutamine, Lecithin and Ginkgo Extract. Necessary minerals such as Calcium, Magnesium and Chromium are included as well. - January 21, 2008 - Mitamins Inc.
Supplement for Emphysema: Enhance and Support Lung Health
From Sunnyvale, California - At Mitamins, a new supplement formula from Dr. Balch, which is targeted at Emphysema has been launched. This natural emphysema formula is focused on lung system recovery and repair. Botanicals such as Ginkgo Biloba, used to help with peripheral circulation, are included alongside powerful immunity-enhancing components such as Astragalus. Smoking- and stress-related nutritional deficiencies are addressed with a variety of essentials. - January 21, 2008 - Mitamins Inc.
Calcium Supplementation and Heart Attack Risk? Vitamin K2 May be a Solution.
Industry expert Scott Rosenbush strongly recommends vitamin K2 supplementation to help ensure bone and heart health. As the most bioactive and longest lasting form of vitamin K, menaquinone-7 is ideal for dietary supplements and functional foods. - January 19, 2008 - P.L. Thomas & Co., Inc.
Trevigen Launches Cultrex BME PathClear
Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc.
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan... - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals
Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000
Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals
FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study
The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals
AnaSpec Introduces Ten New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA... - January 04, 2008 - AnaSpec, EGT Group
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
‘Harsh Goenka Takes a Keen Note of Suchitra Krishnamurty’s Arty Comments’
The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the... - December 30, 2007 - RPG
AnaSpec Introduces Sixteen New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit
AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group
Survey Verifies Link Between Nurses' Illness and Occupational Exposure
Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. - December 19, 2007 - Carmel Pharma
2008: The Year of the Gnu?
A “Gnu” movement is taking hold across the country. People everywhere are chanting, “I want my fiber”. Dietary fiber, that is. People nationwide are proclaiming that the delicious Flavor & Fiber Bars, made by Gnu Foods, are the inspiration for their fiber-obsession. They... - December 18, 2007 - Gnu Foods, LLC
AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group
AnaSpec Releases New Antibodies Brochure
With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group
Cardiovascular Sciences, Inc. Announces Funding Event
Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead... - December 12, 2007 - Cardiovascular Sciences, Inc.
First Laboratory Proven Naturopathic Antifungal Now Available to Fight Candida and Other Yeast and Yeast-Like Organisms
Candidacidin is the first naturopathic defense against yeast (Candida) which has been laboratory proven. Candida is now the fourth most prevalent organism found in bloodstream infections. Laboratory results validating antifungal properties are available on line. - December 08, 2007 - Florida Institute of Yeast
AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Collection of Bcl Peptides
AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 17 New Anti-Tau Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group
Carmel Pharma Introduces the Next Evolution of PhaSeal
Today, Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV. - December 03, 2007 - Carmel Pharma
KEC International Bags Two New Projects Worth Rs. 400 Crores
•Rs. 260 Crores Turnkey contract in Saudi Arabia •Rs. 140 Crores Turnkey contract in Namibia - December 01, 2007 - RPG
KEC International Bags Two New Projects Worth Rs. 637 Crores
•Rs. 391 Crores win in Abu Dhabi; Largest single win ever, in dollar value terms, for KEC •Rs. 246 crores turnkey contract in Algeria - December 01, 2007 - RPG
AnaSpec Celebrates the Holidays with Its Customers
AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM
AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin
AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group
Natural Bodybuilding Competition Preparation Course Proves to be a Winner
Karoline Cerin-Stepic of Victoria, Australia has won her division at the recent Asia-Pacific Bodybuilding Championships. Karoline competed against almost 50 other women in the figure division, and took out first place in the tall class. She attributes much of her success to the IAPC Natural... - November 11, 2007 - Ironpower
AnaSpec Introduces Thirteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death... - November 11, 2007 - AnaSpec, EGT Group
AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes
This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation... - November 09, 2007 - AnaSpec, EGT Group
Live Continuing Education for Pharmacists on the Safe Handling of Hazardous Drugs
Carmel Pharma, manufacturer and distributor of PhaSeal, announced that they are sponsoring a live, accredited continuing education (CE) seminar during this year’s 42nd Annual ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV in December. - November 09, 2007 - Carmel Pharma
New Energy Shot Energy Drink Formula Puts Kick Into Sales for Indianapolis Company
Re-orders are on the rise for a new liquid energy shot energy drink product from Indianapolis-based DMD Pharmaceuticals. The company attributes the on-line spike in re-orders for the EPHRINE Plus® Energy Shot to new national print advertising, as well as the product delivering on its promise of convenience, portability, and a rapid-release energy-boosting formula promoted as “more kick, less can.” - November 03, 2007 - DMD Pharmaceuticals
Xcelience’s Scientific Director Selected to Lead Key Sessions on Upcoming Conferences
Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC
NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services
NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.